Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systems Biology of Flu Vaccines in Aging
NCT05291676Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Nov 2023
- Primary completion
- Apr 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Fluzone Trivalent, influenza virus vaccine, split virion in influenza, sponsored by Yale University. Started Nov 2023; status: recruiting.
02
Drugs
Fluzone Trivalentinfluenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05291676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05291676.